Literature DB >> 3761436

Aggressive treatment of metastatic renal cancer.

M Golimbu, S Al-Askari, A Tessler, P Morales.   

Abstract

Radical nephrectomy and excision of metastases were performed in 21 patients with metastatic renal cell carcinoma. Followup was 12 years. Eight patients had metastases at the time of diagnosis and survived an average of 54 months, with 50 per cent alive 5 years postoperatively. Metastases developed after nephrectomy for localized disease in 13 patients. After extirpation of the secondary lesions these 13 patients survived an average of 38 months and 25 per cent were alive at 5 years. Survival varied with the length of time free of disease. Patients in whom metastases developed later than 2 years after nephrectomy survived 55 months compared to only 22 months for those in whom metastases developed earlier. Survival also was influenced by tumor aggressiveness (reflected by prognostic index number) and completeness of surgical excision of the secondary lesion.

Entities:  

Mesh:

Year:  1986        PMID: 3761436     DOI: 10.1016/s0022-5347(17)45085-3

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  15 in total

1.  Metastatic renal cell carcinoma to the pancreas.

Authors:  Harish Lavu; Charles J Yeo
Journal:  Gastroenterol Hepatol (N Y)       Date:  2011-10

Review 2.  Update in cancer chemotherapy: genitourinary tract cancer, Part 1.

Authors:  J C Wright
Journal:  J Natl Med Assoc       Date:  1987-12       Impact factor: 1.798

3.  Renal cell carcinoma with solitary synchronous pancreaticoduodenal and metachronous periprostatic metastases: report of a case.

Authors:  I Yavaşçaoğlu; N Korun; B Oktay; U Simşek; M Ozyurt
Journal:  Surg Today       Date:  1999       Impact factor: 2.549

4.  Renal cell carcinoma metastatic to the pancreas: results of surgical management.

Authors:  T A Sohn; C J Yeo; J L Cameron; A Nakeeb; K D Lillemoe
Journal:  J Gastrointest Surg       Date:  2001 Jul-Aug       Impact factor: 3.452

5.  Prognostic index of renal carcinomas.

Authors:  D L Répássy
Journal:  Int Urol Nephrol       Date:  1999       Impact factor: 2.370

Review 6.  Surgical treatment of a solitary pancreatic metastasis from renal cell carcinoma: report of a case.

Authors:  K Jingu; K Watanabe; H Yamamoto; Y Fujita; I Honda; S Watanabe; M Nagata; K Sugimoto; Y Watanabe
Journal:  Surg Today       Date:  1998       Impact factor: 2.549

7.  Immunoscintigraphic localization of renal tumours in an extracorporeal perfusion model with a monoclonal antibody against gamma-glutamyltransferase.

Authors:  P Fischer; R P Baum; M Tauber; W Boeckmann; S Weier; J E Scherberich
Journal:  Cancer Immunol Immunother       Date:  1992       Impact factor: 6.968

8.  Differential sensitivity of renal cell carcinoma xenografts towards therapy with interferon-alpha, interferon-gamma, tumor necrosis factor and their combinations.

Authors:  A J Beniers; R J van Moorselaar; W P Peelen; F M Debruyne; J A Schalken
Journal:  Urol Res       Date:  1991

9.  Surgery for secondary tumors of the pancreas.

Authors:  Faisal S Dar; Samrat Mukherjee; Satyajit Bhattacharya
Journal:  HPB (Oxford)       Date:  2008       Impact factor: 3.647

10.  Surgical treatment of renal cell carcinoma metastases: prognostic significance.

Authors:  M Takashi; Y Takagi; T Sakata; T Shimoji; K Miyake
Journal:  Int Urol Nephrol       Date:  1995       Impact factor: 2.370

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.